Xenon Pharmaceuticals Inc (XENE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

200 - 3650 GILMORE WAY BURNABY, BRITISH COLUMBIA, CANADA V5G 48W

Xenon Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company discovers and develops therapeutics for rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies.

Data as of 2021-05-08 11:37:35 -0400
Market Cap758.223 Million Shares Outstanding40.963 Million Avg 30-day Volume169.254 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-12.84 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.60698 52-week High/Low21.94 / 9.32 Next Earnings Date2021-05-10 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from XENE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 1 (0.06%) 0 (0.0%)
Funds Holding: 81 80 1.25% 32 (1.92%) 33 (2.05%) -3.03%
13F shares: 28.033 Million 27.925 Million 0.39% 18.306 Million 17.903 Million 2.25%
% Ownership 80.0787 79.7695 0.39% 52.292 51.1409 2.25%
New Positions: 10 6 66.67% 2 1 100.0%
Increased Positions 25 16 56.25% 9 6 50.0%
Closed Positions 8 5 60.0% 3 2 50.0%
Reduced Positions 21 27 -22.22% 12 17 -29.41%
Total Calls 1 Thousand 0
Total Puts 0 100 -100.0%
PUT/CALL Ratio 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding XENE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XENE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MORTIMER IAN PRESIDENT & CFO

  • Officer
100,000 2021-03-12 1

PIMSTONE SIMON N. CEO

  • Officer
  • Director
225,000 2021-03-12 4

ROBIN SHERRINGTON EVP, STRATEGY & INNOVATION

  • Officer
65,000 2021-03-12 2

EMPFIELD JAMES R. EVP, DRUG DISCOVERY

  • Officer
65,000 2021-03-12 1

VON SEGGERN CHRISTOPHER CHIEF COMMERCIAL OFFICER

  • Officer
60,000 2021-03-12 3

HAYDEN MICHAEL R

  • Director
319,185 2021-02-16 2

AZAB MOHAMMAD

  • Director
63,733 2020-12-15 2

MACHADO PATRICK

  • Director
0 2020-11-05 2

TARNOW MICHAEL M

  • Director
69,713 2020-10-28 3

PATOU GARY

  • Director
36,073 2020-10-28 2

GANNON STEVEN

  • Director
0 2020-06-01 1

SVORONOS DAWN

  • Director
0 2020-06-01 1

DESJARDINS CLARISSA

  • Director
0 2020-06-01 1

HOLLER FRANK A

  • Director
123,225 2020-05-29 1

AYCARDI-FONSECA ERNESTO CMO

  • Officer
0 2020-03-12 0

SCHELLER RICHARD H

  • Director
0 2019-09-16 0

COHEN CHARLES J. VP, BIOLOGY

  • Officer
6,550 2018-12-11 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BIOTECHNOLOGY VALUE TRADING FUND OS LP

BVF PARTNERS OS LTD.

BVF INC/IL

LAMPERT MARK N

  • 10% Owner
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
No longer subject to file 2018-03-27 0

GOLDBERG Y. PAUL SVP, CLINICAL DEVELOPMENT

  • Officer
0 2017-10-23 0

WINQUIST RAYMOND HEAD, TRANSLATIONAL RESEARCH

  • Officer
1,000 2017-08-18 0

EVANS JOHNSTON L

  • Director
0 2015-05-04 0

STEIN EVAN A.

  • Director
No longer subject to file 2015-04-30 0

CORRAINI KAREN G. GEN. COUNSEL & CORP. SECRETARY

  • Officer
0 2015-03-17 0

MX ASSOCIATES, LLP

  • 10% Owner
No longer subject to file 2014-12-31 0

BRIDGER GARY EVP, RESEARCH & DEVELOPMENT

  • Officer
0 2014-11-21 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
XENON PHARMACEUTICALS INC XENE 2021-05-14 22:15:03 UTC -0.6835 0.7335 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 21:45:03 UTC -0.6298 0.6798 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 21:15:03 UTC -0.6298 0.6798 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 20:45:03 UTC -0.5828 0.6328 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 20:15:04 UTC -0.5828 0.6328 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 19:45:02 UTC -0.5828 0.6328 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 19:15:03 UTC -0.5828 0.6328 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 18:45:03 UTC -0.5469 0.5969 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 18:15:03 UTC -0.5469 0.5969 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 17:45:03 UTC -0.5469 0.5969 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 17:15:03 UTC -0.5469 0.5969 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 16:45:03 UTC -0.5425 0.5925 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 16:15:03 UTC -0.5425 0.5925 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 15:45:03 UTC -0.5425 0.5925 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 15:15:02 UTC -0.5425 0.5925 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 14:45:04 UTC -0.5312 0.5812 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 14:15:03 UTC -0.5312 0.5812 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 13:45:03 UTC -0.5312 0.5812 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 13:15:03 UTC -0.5312 0.5812 200000
XENON PHARMACEUTICALS INC XENE 2021-05-14 12:45:03 UTC -0.5312 0.5812 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Enhanced Index Plus Fund XENE -5.0 shares, $-56.7 2020-03-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund XENE -4.0 shares, $-45.36 2020-03-31 N-PORT

Elevate your investments